Orion Capital Management’s Novartis NVS Stock Holding History

Orion Capital Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$78.4K	Hold	500	–	–	0.02%	244
2026 Q1	$76.4K	Hold	500	–	–	0.03%	225
2025 Q4	$68.9K	Sell	500 -33	-6%	-$4.32K	0.02%	237
2025 Q3	$68.4K	Hold	533	–	–	0.02%	242
2025 Q2	$64.5K	Hold	533	–	–	0.02%	221
2025 Q1	$59.4K	Hold	533	–	–	0.03%	226
2024 Q4	$51.9K	Buy	+533	New	+$56.8K	0.02%	233
2024 Q3	–	Sell	-733	Closed	-$78K	–	331
2024 Q2	$78K	Hold	733	–	–	0.04%	177
2024 Q1	$70.9K	Hold	733	–	–	0.04%	198
2023 Q4	$74K	Hold	733	–	–	0.04%	201
2023 Q3	$74.7K	Buy	+733	New	+$74.4K	0.05%	184
2023 Q2	–	Sell	-700	Closed	-$64.4K	–	335
2023 Q1	$64.4K	Hold	700	–	–	0.04%	195
2022 Q4	$63.5K	Sell	700 -189	-21%	-$15.9K	0.05%	178
2022 Q3	$68K	Hold	889	–	–	0.05%	174
2022 Q2	$75K	Hold	889	–	–	0.06%	170
2022 Q1	$78K	Sell	889 -11	-1%	-$952	0.05%	182
2021 Q4	$79K	Sell	900 -550	-38%	-$45.7K	0.04%	178
2021 Q3	$119K	Hold	1,450	–	–	0.07%	149
2021 Q2	$132K	Hold	1,450	–	–	0.08%	132
2021 Q1	$124K	Hold	1,450	–	–	0.09%	127
2020 Q4	$137K	Buy	+1,450	New	+$127K	0.1%	105

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Orion Capital Management's NVS Position: Q2 2026 in Review

Orion Capital Management held its Novartis (NVS) position steady in Q2 2026 at 500 shares worth $78.4K. The position accounts for 0.02% of the portfolio, ranked #244.

Orion Capital Management first reported a position in NVS in Q4 2020 and has held it in 21 quarters since. The position peaked at $137K in Q4 2020. 1,611 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Orion Capital Management held 500 shares of Novartis worth $78.4K as of Q2 2026.
Orion Capital Management left its Novartis share count unchanged in Q2 2026.
Novartis made up 0.02% of Orion Capital Management's portfolio in Q2 2026, its #244 holding.
Orion Capital Management first reported a position in Novartis in Q4 2020 and has held it in 21 quarters since.
Orion Capital Management's Novartis position peaked at $137K in Q4 2020.
1,611 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Orion Capital Management's 13F filing for Q2 2026, filed 18 Aug 2026.